Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated ASP1707 in postmenopausal women with rheumatoid arthritis on methotrexate to assess efficacy and safety. The trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP1707

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED